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  would like to commend Dr Farzin Halabchi and 
colleagues regarding their excellent review article of 
“Sudden cardiac death in young athletes” 
[1]. The 
identification of underlying cardiovascular disease is a 
primary screening objective of physicians who care for 
athletes.  I would like to take this opportunity to clarify 
some points made in the article and make some 
suggestions for future screening and research. 
          There is a lot of debate regarding the use of 
electrocardiogram (ECG) as a universal screening tool 
for cardiac diseases in the preparticipation physical 
exam (PPE). Italy has employed this and has shown a 
significant decrease in their athletes’ mortality from 
sudden cardiac death (SCD). Extrapolation of data 
about ECG screening and decreases in SCD and its 
generalization to other countries has to be done with 
caution. The prevalence of Arrythmogenic Right 
Ventricular Dysplasia in Italy accounts for a large 
proportion of their cases of SCD. This high proportion 
of genetic cardiomyopathy will support the use of ECG 
screening as compared to populations where there are 
lower rates of identifiable cardiac diseases. The rate of 
SCD in Italy prior to national screening is quoted to be 
about 1:28,000 persons per year, with 0.9/100,000 
directly attributable to ARVD. The largest and most 
statistically significant decrease of SCD from a specific 
cause was a decrease in death from ARVD to 
0.15/100,000
[2]. Statistics of SCD from all causes in the 
United States vary from 1/300,000 to 1/160,000
[3]. This 
proportion is much lower than that found in the Italian 
population. The European Society of Cardiology (ESC) 
bases their recommendation of universal ECG 
screening for European athletes on the success of the 
Italian screening program. There is no data looking at 
the incidence of SCD in other European countries. If 
the incidence of SCD is lower along with a decrease 
prevalence of cardiomyopathy, the effectiveness of this 
universal screening protocol comes into question. The 
ESC estimates the cost of adding an ECG to all 
preparticipation evaluations would represent a 50% 
increase in cost
[4]. This only represents about ten Euros, 
but there is no mention of the overall financial effects 
on European health care systems. Their 
recommendations do not take into account the 
availability of access to specialty care in the case of 
abnormal screening tests. This could have a serious 
impact on the health care systems of other European 
countries. The Italian experience has shown that 
universal ECG implementation into the preparticipation 
screening exam saves lives and is a cost effective tool. I 
caution the generalization of this data to a large 
population that varies in its economic and genetic 
diversity. 
     There  is  some  emerging evidence in the United 
States showing a higher incidence of SCD in certain 
populations. A recent study of college athletes shows an 
incidence of SCD to be approximately 1:45,000 college 
athletes per year
[3].  This is a much higher proportion 
than the population based incidence of 1:160,000. 
There have been studies using updated incidence data 
that show an increased sensitivity of detecting causes of 
SCD with mandatory ECG screening. This information 
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has lent itself to research in subpopulations of athletes 
to determine the effectiveness of ECG screening. This 
risk stratification is an area that requires further 
investigation. As opposed to instituting ECGs for an 
entire population of athletes, it may be prudent to 
screen certain populations that are at increased risk of 
SCD. College athletes seem to have a much higher rate 
of SCD than that of high school athletes. Certain sports 
have a higher rate of SCD due to extra physical 
demands. Most cases of SCD occur in football and 
basketball athletes 
[5]. Is the risk of SCD from 
cardiomyopathy the same in a baseball player and a 
football player? Further research into the area of risk 
stratification may be useful to narrow the population of 
athletes that would benefit from ECG screening.  
     Improving the screening test is another mechanism 
that can make a screening program more effective. 
Through eliminating isolated voltage criteria of left 
ventricular hypertrophy as an indication for further 
cardiac evaluations, the false positive rate of the ECG 
drops from about 15% to about 2% 
[3] Studies have 
shown that a normal ECG carries a high negative 
predictive value for hypertrophic cardiomyopathy and 
other causes of SCD
[6]. The combination of an increase 
in incidence of SCD in the United States and decrease 
in the false positive rate of the ECG makes universal 
ECG screening more plausible.  
          Currently, in the USA, financial responsibility of 
receiving a PPE to participate in sports falls on the 
individual. Certain schools and organizations may have 
screening programs, but the majority of individuals 
receives their screening through payment by private 
insurance or out of pocket expense. Adding the cost of 
ECG to PPE screening may be more than institutions or 
individuals are able to afford; therefore, restricting 
access to those with health insurance. This would 
prevent a large population of people from being able to 
participate and benefit from athletic competition. In 
addition to the financial considerations of ECG 
screening in the United States, the implementation of a 
nation-wide screening mandate would be difficult. 
Preparticipation screenings are regulated at the state 
level and there is little uniformity regarding the 
guidelines in different states.  The Preparticipation 
Physical Exam Monograph is a multidisciplinary 
guideline published jointly by the American Academy 
of Family Physicians, American Academy of Pediatrics, 
American College of Sports Medicine, American 
Medical Society of Sports Medicine, American 
Orthopaedic Society for Sports Medicine, and the 
American Osteopathic Academy of Sports Medicine 
that provides the most uniform guideline for performing 
the PPE, but there is no mandate for its use 
[7]. A 
nationwide mandate for standardization of the PPE is 
needed for universal ECG screening to take effect, but 
this is unlikely as healthcare is managed at the state 
level.  
          As a final word of caution, implementation of a 
universal screening program will lead to a certain 
number of false positives requiring further evaluation. 
There will be a subset of athletes that have an 
“abnormal” echocardiogram that may not have 
underlying cardiovascular disease. It may be difficult to 
detect the difference between an athlete with 
Hypertrophic Cardiomyopathy, a life threatening 
condition, and athletic heart, a physiologic adaption to 
exercise. This could lead to a significant number of 
athlete’s being unnecessarily restricted from activity or 
being delayed from activity for extended periods of 
time. In the athlete, this could lead to undo stress. Being 
restricted from sports has been equivocated to the stress 
of death of a close relative 
[8]. 
     Dr.  Halabchi’s  article  discusses  the  plausibility  of 
implementing universal screening for the entire of 
Asian athletes
[1]. Plans for a continent wide screening 
protocol in Asia would be difficult to implement 
considering the vast size of the population and the 
genetic differences of its people. It would be more 
prudent for individual countries to evaluate their 
incidence of SCD and the prevalence of its underlying 
causes. This information would allow for countries to 
institute nationwide guidelines. A wide approach 
towards Asia would not benefit everyone appropriately 
from a medical or financial perspective.   
          In conclusion, ECG screening as part of the PPE 
appears to be a very useful tool. More research needs to 
be done to determine the proper settings to use this 
modality as opposed to using it for universal screening. 
I believe that ECG will become part of medical 
screening in certain settings in the United States. With a 
recognized increase in the incidence of SCD and 
increased specificity of ECG interpretation, use of the  
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ECG as part of the PPE has an important role in 
screening athletes for congenital cardiac disease. Its 
implementation into universal screening remains 
complicated due to the financial and social complexities 
of health care. 
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